Luciole Pharmaceuticals, Inc.
Sherborn, MA
- UEI
- E26HJPMM1E86
- CAGE
- 8RE82
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 49 Green Ln, Sherborn, MA 01770, USA
- Website
- luciolepharma.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Discovery and development of OGG1 activators as precision drugs for modification of alzheimer's disease progression. | National Institute on Aging (NIH) | $501,626 |
Quick answers
Is Luciole Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Luciole Pharmaceuticals, Inc.'s SAM.gov registration is active through May 6, 2027.
What is Luciole Pharmaceuticals, Inc.'s most recent federal award?
Luciole Pharmaceuticals, Inc.'s most recent federal grant award is Discovery and development of OGG1 activators as precision drugs for modification of alzheimer's disease progression (R43AG084412), from National Institute on Aging (NIH), on September 18, 2023.
On GovTribe
See Luciole Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors